AzTrials
AzTrials

PregnancyEXPECTNCT02503995

Exercise in Pregnancy Evaluative Controlled Study

A study testing Physical Exercise Participation in people with Pregnancy, run by Swansea University.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aimed to investigate whether there are measurable differences in CHANS function in pregnant women who receive only standard antenatal care compared with those who additionally undertake a programme of regular physical exercise. Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Pregnancy
What is being tested?
Physical Exercise Participation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
No sites listed yet
Study dates
Mar 2012to May 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Eligible participants were apparently healthy pregnant women aged 18 years or over, with no existing complications of pregnancy at their 12-week dating scan.

Who cannot join

  • Exclusion criteria were: a history of cardiovascular or chronic respiratory problems, sleep apnoea, or central/peripheral nervous system disorder.

About this study

Official title: Influence of Regular Antenatal Physical Exercise on Cardiovascular, Haemodynamic and Autonomic Nervous System (CHANS) Function During and After Pregnancy

This study aimed to investigate whether there are measurable differences in CHANS function in pregnant women who receive only standard antenatal care compared with those who additionally undertake a programme of regular physical exercise.

Read the detailed description

The health benefits of physical exercise in the non-pregnant population are generally appreciated but its influence during pregnancy has not been clearly demonstrated. The focus of this proposal is to obtain for the first time a comprehensive understanding of the influence of regular physical exercise during pregnancy on cardiovascular, haemodynamic and autonomic nervous system (CHANS) parameters during pregnancy and following childbirth. This will involve assessing heart rate variability and cardiac stroke volume. This study will allow the investigators to compare CHANS parameters in pregnant women who are randomly assigned into three groups: a 'standard care' group and two groups who engage in a supervised programme of physical exercise (either land-based or water-based). The investigators will assess CHANS parameters at three stages during pregnancy and on one occasion following childbirth. This will allow the influence of regular (weekly) physical exercise on CHANS physiology to be assessed during advancing gestation. The investigators will thus use this study to provide initial evidence of the health benefits of regular and specific forms of antenatal physical exercise.

Conditions
Pregnancy
Being tested
Physical Exercise Participation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Physical Exercise ParticipationBehavioural

Study groups in NCT02503995
Study groupRoleWhat they receive
No interventionActive comparatorParticipants not undertaking any additional exercise
Receives: Behavioral: Physical Exercise Participation
Water-based exercise groupExperimentalParticipants assigned to a water-based exercise group
Receives: Behavioral: Physical Exercise Participation
Land-based exercise groupExperimentalParticipants assigned to a land-based exercise group
Receives: Behavioral: Physical Exercise Participation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Heart Rate Variability - Time Point 1

    Determined from 3-lead ECG, assessed as absolute value

    Measured: 10-12 weeks gestation

  2. Heart Rate Variability - Time Point 2

    Determined from 3-lead ECG, assessed as absolute value

    Measured: 24-28 weeks gestation

  3. Heart Rate Variability - Time Point 3

    Determined from 3-lead ECG, assessed as absolute value

    Measured: 34-36 weeks gestation

  4. Heart Rate Variability - Time Point 4

    Determined from 3-lead ECG, assessed as absolute value

    Measured: 12 weeks post-birth

  5. Cardiac Stroke Volume - Time Point 1

    Determined from thoracic impedance cardiogram, assessed as absolute value

    Measured: 10-12 weeks gestation

  6. Cardiac Stroke Volume - Time Point 2

    Determined from thoracic impedance cardiogram, assessed as absolute value

    Measured: 24-28 weeks gestation

  7. Cardiac Stroke Volume - Time Point 3

    Determined from thoracic impedance cardiogram, assessed as absolute value

    Measured: 34-36 weeks gestation

  8. Cardiac Stroke Volume - Time Point 4

    Determined from thoracic impedance cardiogram, assessed as absolute value

    Measured: 12 weeks post-birth

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jul 2015 (estimated)
  2. Study startMar 2012
  3. Primary completionMay 2013
  4. Study completionMay 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02503995
Sponsor's protocol ID
12/WA/0081
Acronym
EXPECT
Status last verified
Jul 2015
First submitted
10 Jul 2015
Last updated
22 Jul 2015
Results posted
No
Data monitoring committee
No

Publications

  • Carpenter RE, D'Silva LA, Emery SJ, Uzun O, Rassi D, Lewis MJ. Changes in heart rate variability and QT variability during the first trimester of pregnancy. Physiol Meas. 2015 Mar;36(3):531-45. doi: 10.1088/0967-3334/36/3/531. Epub 2015 Feb 18.

    PubMed 25690105
  • D'Silva LA, Davies RE, Emery SJ, Lewis MJ. Influence of somatic state on cardiovascular measurements in pregnancy. Physiol Meas. 2014 Jan;35(1):15-29. doi: 10.1088/0967-3334/35/1/15. Epub 2013 Dec 17.

    PubMed 24345774
  • Carpenter RE, Emery SJ, Uzun O, D'Silva LA, Lewis MJ. Influence of antenatal physical exercise on haemodynamics in pregnant women: a flexible randomisation approach. BMC Pregnancy Childbirth. 2015 Aug 22;15:186. doi: 10.1186/s12884-015-0620-2.

    PubMed 26296647

Questions about this trial

What is this clinical trial studying?

A study testing Physical Exercise Participation in people with Pregnancy, run by Swansea University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jul 2015. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Heart Rate Variability - Time Point 1 (time frame: 10-12 weeks gestation). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02503995, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jul 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in